Comparations of efficacy and safety of rituximab, calcineurin inhibitors and cyclophosphamide in primary membranous nephropathy: a single-center retrospective analysis

Comparations of efficacy and safety of rituximab, calcineurin inhibitors and cyclophosphamide in primary membranous nephropathy: a single-center retrospective analysis

Abstract Background To compare the efficacy and safety of rituximab (RTX), calcineurin inhibitor (CNI) and cyclophosphamide (CTX) plus glucocorticoids in the treatment of primary membranous nephropathy (PMN). Methods Totally 478 biopsy-proven PMN patients in single center were retrospectively includ...

Full description

Bibliographic Details
Main Authors: Luying Lu, Shasha Cai, Huayan Zhu, Guangjun Liu, Yaomin Wang, Pingping Ren, Lan Lan, Xiaoqi Shen, Liangliang Chen, Ying Xu, Jun Cheng, Xiayu Li, Jianghua Chen, Fei Han
Format: Article
Language:English
Published: BMC 2024-12-01
Series:BMC Nephrology
Subjects:
Primary membranous nephropathy
Calcineurin inhibitor
Cyclophosphamide
Rituximab
Online Access:https://doi.org/10.1186/s12882-024-03912-4

Internet

https://doi.org/10.1186/s12882-024-03912-4

Similar Items